Russell Investments Group Ltd. raised its position in shares of Amdocs Limited (NASDAQ:DOX – Free Report) by 5.6% in the third quarter, HoldingsChannel reports. The firm owned 978,940 shares of the technology company’s stock after acquiring an additional 51,548 shares during the period. Russell Investments Group Ltd.’s holdings in Amdocs were worth $80,307,000 as of its most recent SEC filing.
Other hedge funds have also made changes to their positions in the company. Pzena Investment Management LLC grew its position in shares of Amdocs by 0.6% during the 3rd quarter. Pzena Investment Management LLC now owns 6,593,249 shares of the technology company’s stock worth $540,976,000 after buying an additional 42,184 shares in the last quarter. LSV Asset Management raised its holdings in shares of Amdocs by 7.6% in the third quarter. LSV Asset Management now owns 3,648,703 shares of the technology company’s stock valued at $299,376,000 after acquiring an additional 257,193 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in Amdocs by 3.0% in the third quarter. Allspring Global Investments Holdings LLC now owns 3,111,312 shares of the technology company’s stock worth $252,856,000 after acquiring an additional 91,428 shares during the period. Vanguard Group Inc. lifted its stake in Amdocs by 0.3% in the third quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company’s stock worth $251,602,000 after acquiring an additional 9,207 shares during the period. Finally, Dimensional Fund Advisors LP grew its holdings in Amdocs by 7.4% during the 3rd quarter. Dimensional Fund Advisors LP now owns 2,332,381 shares of the technology company’s stock worth $191,366,000 after acquiring an additional 160,040 shares in the last quarter. 92.02% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
DOX has been the topic of a number of research reports. Stifel Nicolaus cut their target price on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, February 4th. Wolfe Research reaffirmed a “peer perform” rating on shares of Amdocs in a research report on Thursday, November 13th. Barclays dropped their price objective on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 4th. Weiss Ratings reissued a “hold (c)” rating on shares of Amdocs in a report on Tuesday, January 27th. Finally, Wall Street Zen raised shares of Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, Amdocs presently has a consensus rating of “Moderate Buy” and an average target price of $92.33.
Amdocs Price Performance
DOX opened at $69.24 on Tuesday. The firm has a market capitalization of $7.47 billion, a PE ratio of 13.39, a price-to-earnings-growth ratio of 1.23 and a beta of 0.42. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.06 and a quick ratio of 1.06. The business’s 50-day moving average is $76.16 and its two-hundred day moving average is $79.70. Amdocs Limited has a 1 year low of $65.74 and a 1 year high of $95.41.
Amdocs (NASDAQ:DOX – Get Free Report) last released its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 EPS for the quarter, beating the consensus estimate of $1.75 by $0.06. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The business had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.15 billion. During the same period in the prior year, the firm posted $1.66 earnings per share. The company’s quarterly revenue was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. Research analysts anticipate that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.
Amdocs Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Tuesday, March 31st will be paid a $0.569 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 3.3%. This is a boost from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date is Tuesday, March 31st. Amdocs’s dividend payout ratio (DPR) is 40.81%.
Amdocs Company Profile
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
Featured Articles
- Five stocks we like better than Amdocs
- The Market Just Split in Two (URGENT)
- Buy this Gold Stock Before May 15th, 2026
- J.P. Morgan is betting on this coin
- Central banks just did something they haven’t done since 1967
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
